Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 741Carcinoma, Renal Cell 237Urinary Bladder Neoplasms 210Carcinoma, Transitional Cell 116Breast Neoplasms 101Kidney Neoplasms 98Neoplasms 89Carcinoma, Non-Small-Cell Lung 86Melanoma 83Ovarian Neoplasms 82Colorectal Neoplasms 75Neoplasm Metastasis 71Non-Muscle Invasive Bladder Neoplasms 58Lung Neoplasms 56Pancreatic Neoplasms 48Endometrial Neoplasms 46Sarcoma 45Stomach Neoplasms 42Uterine Cervical Neoplasms 41Carcinoma, Hepatocellular 36Adenocarcinoma 36Wilms Tumor 34Esophageal Neoplasms 32Triple Negative Breast Neoplasms 31Squamous Cell Carcinoma of Head and Neck 31Head and Neck Neoplasms 28Testicular Neoplasms 26Metastatic Castration-resistant Prostate Cancer 25Neuroblastoma 23Disease 23

Interventions

Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lipodystrophy, Congenital Generalized × Genitourinary × 90 days × Clear all
NCT05888532 2026-03-17

64Cu-GRIP B in Patients With Advanced Malignancies

University of California, San Francisco

Phase 1/2 Recruiting
91 enrolled
Genitourinary

Kidney Neoplasms, Prostatic Neoplasms, Urethral Neoplasms, Lipodystrophy, Congenital Generalized

Data powered by HemOnc (CC BY 4.0) Colophon âš¡